These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29427009)

  • 1. Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations.
    Zhao X; Cheng Y; Gan Y; Jia R; Zhu L; Sun X
    Clin Rheumatol; 2018 May; 37(5):1229-1237. PubMed ID: 29427009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
    Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
    Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
    J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus.
    Meng Y; Zhang M; Zhao X; Cheng Y; Jia R; Wang Y; Sun X
    Clin Rheumatol; 2018 Oct; 37(10):2707-2714. PubMed ID: 29998369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
    Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
    PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
    Syahidatulamali CS; Wan Syamimee WG; Azwany YN; Wong KK; Che Maraina CH
    J Postgrad Med; 2017; 63(4):257-261. PubMed ID: 28862243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
    Zhou Z; Xu A; Teng J; Wang F; Tan Y; Liu H; Cheng X; Su Y; Shi H; Hu Q; Chi H; Li J; Hou J; Sun Y; Yang C; Ye J
    J Immunol Res; 2020; 2020():2180708. PubMed ID: 33224991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
    Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
    Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
    Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K
    Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The homogeneous multiplexed system--a new method for autoantibody profile in systemic lupus erythematosus.
    Zandman-Goddard G; Gilburd B; Shovman O; Blank M; Berdichevski S; Langevitz P; Shoenfeld Y
    Clin Dev Immunol; 2005 Jun; 12(2):107-11. PubMed ID: 16050141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations].
    Alpa M; Ferrero B; Cavallo R; Naretto C; Gennaro M; Bellizia L; Sena LM; Roccatello D
    G Ital Nefrol; 2002; 19(6):617-21. PubMed ID: 12508165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
    Su Y; Jia RL; Han L; Li ZG
    Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A; Nikolaisen C; Nossent HC
    Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
    Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
    Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.